<DOC>
	<DOCNO>NCT01364558</DOCNO>
	<brief_summary>The purpose clinical research study assess bioavailability pharmacokinetics two formulation diazepam intranasal ( nasal spray ) injectable diazepam intravenous ( I.V . ) administration</brief_summary>
	<brief_title>A Study Diazepam After Intranasal Intravenous Administration Healthy Volunteers</brief_title>
	<detailed_description>Diazepam medication use treatment seizure . It approve Food Drug Administration ( FDA ) use United States currently sell Valium® tablet , Diazepam Injection Diastat® rectal gel . This study evaluate two intranasal ( nasal spray ) formulation diazepam supply Neurelis , Inc . The purpose clinical research study assess bioavailability pharmacokinetics two formulation diazepam intranasal ( nasal spray ) injectable diazepam intravenous ( I.V . ) administration . `` Bioavailability '' measure much drug absorb present blood . `` Pharmacokinetics '' mean study way drug enters leave blood tissue time</detailed_description>
	<mesh_term>Diazepam</mesh_term>
	<criteria>1 . Male female subject age 18 45 year ( inclusive ) . 2 . Written inform consent participate study . 3 . Body mass index ( BMI ) 19 30 kg/m² , inclusive . 4 . Female subject childbearing potential , define surgically sterile least two year ( 2 ) postmenopausal , must agree use one follow form contraception three ( 3 ) month prior 12 day follow last dose study drug : hormonal ( oral , transdermal , implant , injection ) , barrier ( condom , diaphragm spermicide ) , IUD , vasectomize partner ( six month minimum ) . Subjects must use method least three ( 3 ) month prior start study . 5 . No clinically significant abnormal finding medical history , physical examination , electrocardiogram ( ECG ) , clinical laboratory result Screening . 6 . Subjects must agree return study site study visit , include three ( 3 ) confinement period , must willing comply require study procedure . 1 . A history clinically significant gastrointestinal , renal , hepatic , neurologic , hematologic , endocrine , oncologic , pulmonary , immunologic , psychiatric , cardiovascular disease , severe seasonal non seasonal allergy , nasal polyp nasal passage abnormality could interfere nasal spray administration , condition , opinion Principal Investigator , would jeopardize safety subject impact validity study result . 2 . A history allergic adverse response diazepam comparable similar product . 3 . Subjects ( whatever reason ) abnormal diet ( one severely restrict specific basic food group [ e.g. , ketogenic diet ] , limit calorie [ e.g. , fast ] , and/or require use daily supplement substitute food typically eat mealtime ) , four ( 4 ) week precede study . 4 . Subjects donate blood plasma within 30 day first dose study drug . 5 . Participation clinical trial within 30 day prior first dose study drug . Participation observational ( non interventional ) study exclude long scheduling conflict study . 6 . Inadequate difficult venous access may jeopardize quality time PK sample . 7 . Use counter ( OTC ) medication , include vitamin , within seven ( 7 ) day prior first dose study drug study , unless approve Principal Investigator . 8 . Use prescription medication , include benzodiazepine , within 14 day prior first dose study drug study , exception hormonal contraceptive woman childbearing potential , unless approve Principal Investigator . 9 . Treatment known enzyme alter drug barbiturate , phenothiazine , cimetidine , carbamazepine , etc. , within 30 day prior first dose study drug study . 10 . Smoking use tobacco product within six ( 6 ) month prior first dose study drug study . 11 . Female subject try conceive , pregnant , lactate . 12 . Positive serum pregnancy test Screening urine pregnancy test prior administration study drug woman , regardless childbearing potential . 13 . Positive blood screen HIV , Hepatitis B surface antigen ( HbSAg ) , Hepatitis C , positive urine screen alcohol , drug abuse , cotinine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>